Risk for posttransplant diabetes mellitus with current immunosuppressive medications

This publication has 71 references indexed in Scilit:

• ONE-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL OF FK506 FOR PRIMARY KIDNEY TRANSPLANTATION1
  Transplantation, 1996
• A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1
  Transplantation, 1996
• The Efficacy And Toxicity Of Rapamycin In Murine Islet Transplantation
  Transplantation, 1993
• THE USE OF MYCOPHENOLATE MOFETIL (RS-61443) IN HUMAN HEART TRANSPLANT RECIPIENTS
  Transplantation, 1993
• RECOVERY AND HYPERSECRETION OF INSULIN AND REVERSAL OF INSULIN RESISTANCE AFTER WITHDRAWAL OF SHORT-TERM CYCLOSPORINE TREATMENT
  Transplantation, 1992
• EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS
  Transplantation, 1991
• Liver, Kidney, and Thoracic Organ Transplantation Under FK 506
  Annals of Surgery, 1990
• POSTTRANSPLANT HYPERGLYCEMIA
  Transplantation, 1989
• TOXIC EFFECTS OF CYCLOSPORINE ON THE ENDOCRINE PANCREAS OF WISTAR RATS
  Transplantation, 1985
• EFFECTS OF CYCLOSPORIN ON PREDNISOLONE METABOLISM
  The Lancet, 1984